We are accelerating equitable access to reliable diagnosis around the world.
Foundation for Innovative New Diagnostics concentrates on diagnostics that can move from development into use: antigen rapid diagnostic tests, tuberculosis tools, and digital and laboratory support that helps those tests work in the field. A single grant to Biomeme for diagnostic test development reached $4,015,000 in 2023, and the foundation also backed Transnational TechnologiesInc with $3,200,000 for manufacturing and commercialization of an antigen RDT for COVID. Those awards show a pattern of supporting both product creation and the steps needed to bring diagnostics to market. The foundation’s portfolio also includes implementation work, such as support for scaling COVID antigen tests in the Americas and use of rapid tests in humanitarian settings, along with research and evaluation grants to academic and nonprofit partners. Its stated mission is to accelerate equitable access to reliable diagnosis around the world, and the recent awards reflect that through work on TB elimination, point-of-care diagnostics, pathogen genomic surveillance, and access-oriented technologies for low- and middle-income countries.
In diagnostics development, Foundation for Innovative New Diagnostics gave $1,012,297 to Diagnostic Consulting Network Inc in 2024 for development of diagnostic tests, and $355,100 to Broad Institute in 2024 for a rapid, point-of-care diagnostic for high-sensitivity detection of tuberculosis. The foundation also supported COVID and antigen test work, including $793,500 to Elizabeth Glaser Pediatric Aids Foundation for evaluation of antigen rapid diagnostic tests. Beyond test design, it funds enabling tools and infrastructure: DimagiInc received $252,335 for mobile phone apps that collect data from rapid in vitro diagnostic tests and help users interpret results. It also backed genomics training for Africa CDC workforce development through Program Appropriate Tech in Health, linking diagnostics to surveillance capacity.
Typical grant size sits at a p25 of $39,206, a median of $190,400, and a p75 of $548,709, showing a mix of smaller support grants and larger awards. The recent record includes repeat recipients across multiple years, including Biomeme, CHAI-Clinton Health Access Initiation Inc, Diagnostic Consulting Network, and University of North Carolina, which suggests ongoing relationships rather than one-off awards. The foundation is a public charity and a regular funder, not a DAF vehicle. It does not fund individuals and does not make program-related investments. No application process is described in the data.
$1.4M
$51.3M
$49.3M
$56.8M
Most grants fall between $39K and $549K, with a median of $190K.
25th Percentile
$39K
Median
$190K
75th Percentile
$549K
Sign up for a free Kindora account to access AI-generated insights into this funder's giving patterns, decision-makers, and fit signals.
Get Started FreeFree Kindora accounts unlock side-by-side comparisons with foundations that share this funder's focus areas and giving profile.
Get Started FreeSign up free to see how well your nonprofit fits this funder, get an AI-generated pitch, and unlock similar foundations.
All recent grants in the dataset went to US recipients, with 63 grants and 100.0% of grants landing in the United States. The strongest clusters are in Massachusetts, California, and Washington, DC, with additional awards in North Carolina, Pennsylvania, Florida, Texas, New York, Connecticut, and Virginia. Recipient cities that appear repeatedly include Cambridge, Boston, Washington, DC, Chapel Hill, Carlsbad, Philadelphia, and Shelton. The headquarters is in Grandsaconnex, but the grantmaking shown here is entirely US-based.
The recent grants show support for diagnostic test development, tuberculosis diagnostics, antigen rapid diagnostic tests, pathogen genomic surveillance, digital tools for RDT use, and access-oriented implementation work. Examples include development of diagnostic tests, TB elimination efforts, and mobile apps that help users interpret rapid test results.
The grant-size distribution is p25 $39,206, median $190,400, and p75 $548,709. Recent awards range from smaller consulting and research grants to multi-million-dollar development and commercialization grants.
Yes. Several recipients appear in multiple years, including Biomeme, CHAI-Clinton Health Access Initiation Inc, Diagnostic Consulting Network, and University of North Carolina. That pattern points to recurring relationships in addition to one-time awards.
In the recent-grants data, every grant goes to a US recipient, with 63 grants and 100.0% in the United States. Repeated recipient locations include Cambridge, Boston, Washington, DC, Chapel Hill, and Carlsbad.
Foundation for Innovative New Diagnostics is a public charity and a regular funder. It does not fund individuals and does not make program-related investments.
2025
Source: IRS Form 990-PF, fiscal year 2025.
Most recent grants reported to the IRS.
| Recipient | Location | Amount | Year | Purpose |
|---|---|---|---|---|
| UNIVERSITY OF NORTH CAROLINA | Chapel Hill, NC | $506,168 | 2025 | LABORATORY STRENGTHENING TO SUPPORT CLINICAL CARE AND RESEARCH |
| DIAGNOSTIC CONSULTING NETWORK | CARLSBAD, CA | $410,848 | 2025 | DEVELOPMENT OF DIAGNOTIC TESTS |
| Clinton Health Access Initiative Inc | BOSTON, MA | $288,213 | 2025 | TO SUPPORT TB ELIMINATION EFFORTS |
| American Society of Tropical Med | Oakbrook Terrace, IL | $50,000 | 2025 | PUBLICATION OF JOURNAL SUPPLEMENT |
| QUANTIGEN | FISHER, IN | $40,570 | 2025 | ACCELERATING TOOLS TO DRIVE TUBERCULOSIS DETECTION |
| Program appropriate Tech in Health | SEATTLE, WA | $40,119 | 2025 | GENOMICS TRAININGS. SUPPORTING THE AFRICA CDC WORKFORCE DEVELOPMENT EFFORT FOR PATHOGEN GENOMIC SURVEILLANCE |
| DIMAGI INC | Cambridge, MA | $30,457 | 2025 | PRODUCTION OF MOBILE PHONE APPS THAT COLLECTS DATA FROM RAPID VITRO DIAGNOSTIC TEST AND THAT CAN AID AN RDT USER IN INTERPRETING THE TEST RESULTS |
| Georgetown University Center for Global Health Practice and Impact | WASHINGTON, DC | $24,922 | 2025 | DRIVING EQUITABLE ACCESS TO TESTING IN LMICS THROUGH EFFECTIVE AND AFFORDABLE TESTS AND INFRASTRUCTURE |
| Drugs & Diagnostics for Tropical Diseases | SAN DIEGO, CA | $10,011 | 2025 | RAPID DIAGNOSTIC TESTING FOR BURULI ULCER |
| HARVARD COLLEGE | cambridge, MA | $9,802 | 2025 | PROJECT AGREEMENT WITH HARVARD FOR SEQ&TREAT MUTATIONS CATALOGUE WORK |
| Diagnostic Consulting Network Inc | Carlsbad, CA | $1,012,297 | 2024 | Development of diagnotic tests |
| CHAI -Clinton Health Access Initiation Inc | Boston, MA | $723,586 | 2024 | To support TB elimination efforts |
| Biomeme | Philadelphia, PA | $685,000 | 2024 | Development of diagnotic tests |
| Baylor College of Medicine | Houston, TX | $548,709 | 2024 | Driving Equitable Access to Testing in LMICs through Effective and Affordable Tests and Infrastructure. |
| University of North Carolina | Chapel Hill, NC | $526,828 | 2024 | Laboratory strengthening to support clinical care and research |
| Georgetown University | Washington, DC | $400,000 | 2024 | Driving Equitable Access to Testing in LMICs through Effective and Affordable Tests and Infrastructure. |
| Broad Institute | Cambridge, MA | $355,100 | 2024 | Development of a rapide, point-of-care diagnostic for high sensitivity detection of Tuberculosis |
| The Regents of the University of California San Diego School of Medicine | La Jolla, CA | $338,978 | 2024 | Consulting services and blood culture due diligence support |
| Elizabeth Glaser Pediatric Aids Foundation | Washington, DC | $206,993 | 2024 | Evaluation of Antigen Rapid Diagnostic Tests. |
| Program Appropriate Tech in Health | Seattlle, WA | $206,912 | 2024 | Genomics trainings. Supporting the Africa CDC Workforce Development Effort for Pathogen Genomic Surveillance |
| Boston University | Boston, MA | $159,966 | 2024 | Sponsored Research |
| University of Alabama | Birmingham, AL | $75,348 | 2024 | Study to support clinical performance evaluation of Gonorrhoea |
| Meso Scale Diagnostics LLC | Rockville, MD | $56,128 | 2024 | Immunofluorescent TB LAM assay for TB diagnosis. |
| Dimagi Inc | Cambridge, MA | $51,218 | 2024 | Production of mobile phone apps that collects data from rapid vitro diagnostic test and that can aid an RDT user in interpreting the test results |
| Audere | Seattle, WA | $49,234 | 2024 | Develop and make available digital tools for lay users to promote proper performance of CV-19 antigen RDTs and reporting of the results (ST project) |
| Harvard College | Cambridge, MA | $39,206 | 2024 | Project agreement with Harvard for Seq&Treat mutations catalogue work |
| Quantigen LLC | Fishers, IN | $22,491 | 2024 | Accelerating tools to drive tuberculosis detection |
| Wolf Greenfield and Sacks PC | Boston, MA | $22,023 | 2024 | IP landscape study directed to the detection of NGAL/LCN-2 biomarkers |
| University of Washington | Seattle, WA | $18,772 | 2024 | Perform assessment of acceptability and usability of HCV self-testing among people who inject drugs in Kenya |
| Boston Children's Hospital | Boston, MA | $7,708 | 2024 | Research agreement for cross-cutting diseases |
| Biomeme | Philadelphia, PA | $4,015,000 | 2023 | Development of diagnostic tests |
| Transnational TechnologiesInc | Windermere, FL | $3,200,000 | 2023 | Supportmanufacturingandcommercializationof antigenrdtforcovid |
| WHO-PAHO | Washington, DC | $2,275,676 | 2023 | Scaling-uptheuseofcovidantigenrapiddiagnost ic tests in Americas testsinAmericas testsinAmericas |
| CHAI-ClintonHealthAccessInitiationInc | Boston, MA | $2,007,458 | 2023 | TosupportTBeliminationefforts |
| DiagnosticConsultingNetworkInc | Carlsbad, CA | $854,249 | 2023 | Developmentofdiagnostictests |
| Elizabeth Glaser Pediatric Aids Foundation | Washington, DC | $793,500 | 2023 | Evaluation of Antigen Rapid Diagnostic Tests |
| ColumbiaUniversity | new york, NY | $792,000 | 2023 | ImplementationofcovidagRDTsinSouthSudan |
| Boston University | BOSTON, MA | $655,323 | 2023 | Sponsored Research |
| UniversityofNorthCarolina | ChapelHill, NC | $644,191 | 2023 | Laboratorystrengtheningtosupportclinicalcare andresearch |
| ManagementSciencesforHealth | cambridge, MA | $621,481 | 2023 | Undertake a project in the field of in vitro diagnostics and COVID |
| Program Appropriate Tech in Health | Seattlle, WA | $312,583 | 2023 | Genomics trainings. Supporting the Africa CDC Workforce Development Effort for Pathogen Genomic Surveillance |
| Perkinelmer Health Sciences Inc | Shelton, CT | $300,000 | 2023 | Develop and register with SRAs a Product that complies with the product requirements for commercialization |
| DimagiInc | Cambridge, MA | $252,335 | 2023 | Productionofmobilephoneappsthatcollectsdata fromrapidvitrodiagnostictestandthatcanaid anRDTuserininterpretingthetestresults |
| International Rescue Committee Inc | New York, NY | $224,051 | 2023 | Supporting the use of rapid diagnostic tests for COVID-19 in humanitarian settings |
| WolfGreenfieldandSacksPC | Boston, MA | $211,332 | 2023 | IPlandscapestudydirectedtothedetectionof NGAL/LCN-2biomarkers |
| Sherlock Biosciences Inc | Watertown, MA | $202,000 | 2023 | COVID 19 molecular platform evaluation |
| BroadInstitute | Cambridge, MA | $190,400 | 2023 | Developmentofarapide,point-of carediagnosticforhighsensitivitydetectionof Tuberculosis |
| Audere | Seattle, WA | $147,704 | 2023 | Develop and make available digital tools for lay users to promote proper performance of CV-19 antigen RDTs and reporting of the results (ST project) |
| Exponent | natick, MA | $122,200 | 2023 | Technical Dossier review for submission of a regulatory package to the World Health Organization "WHO" |
| UniversityofAlabama | Birmingham, AL | $119,140 | 2023 | Studytosupportclinicalperformanceevaluation ofGonorrhoea |
UNIVERSITY OF NORTH CAROLINA
$506,168LABORATORY STRENGTHENING TO SUPPORT CLINICAL CARE AND RESEARCH
DIAGNOSTIC CONSULTING NETWORK
$410,848DEVELOPMENT OF DIAGNOTIC TESTS
Clinton Health Access Initiative Inc
$288,213TO SUPPORT TB ELIMINATION EFFORTS
QUANTIGEN
$40,570ACCELERATING TOOLS TO DRIVE TUBERCULOSIS DETECTION
GENOMICS TRAININGS. SUPPORTING THE AFRICA CDC WORKFORCE DEVELOPMENT EFFORT FOR PATHOGEN GENOMIC SURVEILLANCE
DIMAGI INC
$30,457PRODUCTION OF MOBILE PHONE APPS THAT COLLECTS DATA FROM RAPID VITRO DIAGNOSTIC TEST AND THAT CAN AID AN RDT USER IN INTERPRETING THE TEST RESULTS
DRIVING EQUITABLE ACCESS TO TESTING IN LMICS THROUGH EFFECTIVE AND AFFORDABLE TESTS AND INFRASTRUCTURE
Drugs & Diagnostics for Tropical Diseases
$10,011RAPID DIAGNOSTIC TESTING FOR BURULI ULCER
PROJECT AGREEMENT WITH HARVARD FOR SEQ&TREAT MUTATIONS CATALOGUE WORK
Diagnostic Consulting Network Inc
$1,012,297Development of diagnotic tests
Biomeme
$685,000Development of diagnotic tests
Driving Equitable Access to Testing in LMICs through Effective and Affordable Tests and Infrastructure.
University of North Carolina
$526,828Laboratory strengthening to support clinical care and research
Driving Equitable Access to Testing in LMICs through Effective and Affordable Tests and Infrastructure.
Development of a rapide, point-of-care diagnostic for high sensitivity detection of Tuberculosis
The Regents of the University of California San Diego School of Medicine
$338,978Consulting services and blood culture due diligence support
Elizabeth Glaser Pediatric Aids Foundation
$206,993Evaluation of Antigen Rapid Diagnostic Tests.
Genomics trainings. Supporting the Africa CDC Workforce Development Effort for Pathogen Genomic Surveillance
University of Alabama
$75,348Study to support clinical performance evaluation of Gonorrhoea
Meso Scale Diagnostics LLC
$56,128Immunofluorescent TB LAM assay for TB diagnosis.
Dimagi Inc
$51,218Production of mobile phone apps that collects data from rapid vitro diagnostic test and that can aid an RDT user in interpreting the test results
Audere
$49,234Develop and make available digital tools for lay users to promote proper performance of CV-19 antigen RDTs and reporting of the results (ST project)
Project agreement with Harvard for Seq&Treat mutations catalogue work
Quantigen LLC
$22,491Accelerating tools to drive tuberculosis detection
Wolf Greenfield and Sacks PC
$22,023IP landscape study directed to the detection of NGAL/LCN-2 biomarkers
University of Washington
$18,772Perform assessment of acceptability and usability of HCV self-testing among people who inject drugs in Kenya
Biomeme
$4,015,000Development of diagnostic tests
Transnational TechnologiesInc
$3,200,000Supportmanufacturingandcommercializationof antigenrdtforcovid
WHO-PAHO
$2,275,676Scaling-uptheuseofcovidantigenrapiddiagnost ic tests in Americas testsinAmericas testsinAmericas
DiagnosticConsultingNetworkInc
$854,249Developmentofdiagnostictests
Elizabeth Glaser Pediatric Aids Foundation
$793,500Evaluation of Antigen Rapid Diagnostic Tests
UniversityofNorthCarolina
$644,191Laboratorystrengtheningtosupportclinicalcare andresearch
ManagementSciencesforHealth
$621,481Undertake a project in the field of in vitro diagnostics and COVID
Genomics trainings. Supporting the Africa CDC Workforce Development Effort for Pathogen Genomic Surveillance
Perkinelmer Health Sciences Inc
$300,000Develop and register with SRAs a Product that complies with the product requirements for commercialization
DimagiInc
$252,335Productionofmobilephoneappsthatcollectsdata fromrapidvitrodiagnostictestandthatcanaid anRDTuserininterpretingthetestresults
International Rescue Committee Inc
$224,051Supporting the use of rapid diagnostic tests for COVID-19 in humanitarian settings
WolfGreenfieldandSacksPC
$211,332IPlandscapestudydirectedtothedetectionof NGAL/LCN-2biomarkers
Sherlock Biosciences Inc
$202,000COVID 19 molecular platform evaluation
Developmentofarapide,point-of carediagnosticforhighsensitivitydetectionof Tuberculosis
Audere
$147,704Develop and make available digital tools for lay users to promote proper performance of CV-19 antigen RDTs and reporting of the results (ST project)
Exponent
$122,200Technical Dossier review for submission of a regulatory package to the World Health Organization "WHO"
UniversityofAlabama
$119,140Studytosupportclinicalperformanceevaluation ofGonorrhoea